First Time Loading...

Adaptive Biotechnologies Corp
NASDAQ:ADPT

Watchlist Manager
Adaptive Biotechnologies Corp Logo
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Watchlist
Price: 3.21 USD 11.07% Market Closed
Updated: Mar 29, 2024

Income Statement

Earnings Waterfall
Adaptive Biotechnologies Corp

Revenue
170.3m USD
Cost of Revenue
-75.6m USD
Gross Profit
94.7m USD
Operating Expenses
-296.3m USD
Operating Income
-201.6m USD
Other Expenses
-23.6m USD
Net Income
-225.3m USD

Income Statement
Adaptive Biotechnologies Corp

Rotate your device to view
Income Statement
Currency: USD
Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
56
N/A
59
+5%
69
+18%
78
+13%
85
+9%
93
+10%
92
-1%
92
+0%
98
+6%
116
+18%
133
+15%
147
+10%
154
+5%
155
+0%
160
+3%
168
+5%
185
+10%
184
-1%
190
+3%
180
-5%
170
-5%
Gross Profit
Cost of Revenue
(20)
(21)
(21)
(22)
(22)
(23)
(22)
(22)
(23)
(27)
(33)
(41)
(49)
(53)
(55)
(56)
(58)
(63)
(68)
(73)
(76)
Gross Profit
36
N/A
38
+5%
48
+26%
56
+18%
63
+11%
71
+13%
70
0%
70
0%
76
+8%
89
+17%
100
+13%
105
+5%
105
0%
102
-3%
105
+3%
112
+7%
127
+13%
121
-5%
122
+0%
107
-12%
95
-12%
Operating Income
Operating Expenses
(86)
(95)
(107)
(125)
(141)
(164)
(184)
(203)
(229)
(248)
(273)
(297)
(314)
(331)
(337)
(333)
(326)
(315)
(311)
(302)
(296)
Selling, General & Administrative
(45)
(50)
(56)
(63)
(69)
(80)
(91)
(100)
(111)
(121)
(133)
(152)
(170)
(184)
(190)
(187)
(183)
(177)
(178)
(176)
(173)
Research & Development
(39)
(43)
(50)
(61)
(71)
(82)
(92)
(101)
(116)
(126)
(138)
(143)
(142)
(141)
(136)
(130)
(123)
(119)
(116)
(111)
(122)
Depreciation & Amortization
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(6)
(11)
(16)
(20)
(19)
(18)
(15)
(2)
Operating Income
(50)
N/A
(57)
-14%
(59)
-5%
(68)
-15%
(78)
-15%
(93)
-19%
(114)
-22%
(133)
-17%
(153)
-15%
(159)
-4%
(172)
-8%
(192)
-11%
(209)
-9%
(229)
-10%
(232)
-1%
(221)
+5%
(199)
+10%
(194)
+2%
(190)
+2%
(195)
-3%
(202)
-3%
Pre-Tax Income
Interest Income Expense
3
4
4
7
10
11
12
9
7
4
3
2
2
1
1
1
(0)
(1)
(1)
(1)
2
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
(2)
(2)
(2)
(2)
0
0
0
(25)
Pre-Tax Income
(46)
N/A
(52)
-13%
(56)
-6%
(61)
-10%
(69)
-12%
(82)
-19%
(101)
-24%
(123)
-22%
(146)
-18%
(155)
-6%
(169)
-9%
(189)
-12%
(207)
-9%
(229)
-11%
(232)
-1%
(222)
+5%
(200)
+10%
(195)
+3%
(191)
+2%
(196)
-3%
(225)
-15%
Net Income
Tax Provision
0
0
0
0
0
0
2
1
0
(0)
(2)
(1)
0
0
0
0
0
0
0
0
0
Income from Continuing Operations
(46)
(52)
(56)
(61)
(69)
(82)
(100)
(122)
(146)
(155)
(171)
(191)
(207)
(229)
(232)
(222)
(200)
(195)
(191)
(196)
(225)
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
(46)
N/A
(53)
-14%
(56)
-7%
(62)
-10%
(70)
-12%
(82)
-18%
(100)
-21%
(122)
-23%
(146)
-20%
(155)
-6%
(171)
-10%
(190)
-11%
(207)
-9%
(229)
-11%
(232)
-1%
(222)
+5%
(200)
+10%
(195)
+3%
(191)
+2%
(196)
-3%
(225)
-15%

See Also

Discover More